Developing new methods to create complex bioactive molecules for cancer and infectious disease treatment
New Methods and Strategies for the Scalable Synthesis of Complex Bioactive Molecules
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS DALLAS · NIH-11143171
This study is working on new ways to create special molecules that could help make better medicines for cancer, brain disorders, and infections, with the hope that these advancements will lead to new treatments for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS DALLAS (nih funded) |
| Locations | 1 site (RICHARDSON, UNITED STATES) |
| Trial ID | NIH-11143171 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative methods for synthesizing complex bioactive molecules that could be used in treating cancer, neurological disorders, and infectious diseases. By exploring the rapid assembly of polycyclic frameworks with multiple chiral centers, the team aims to produce both natural and synthetic compounds that have therapeutic potential. The project seeks to overcome existing challenges in accessing these compounds, which are crucial for drug development, by developing new chemical transformations and synthesis techniques. Patients may benefit from the eventual development of new medications derived from these complex molecules.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer, neurological disorders, or infectious diseases who may benefit from novel therapeutic approaches.
Not a fit: Patients with conditions unrelated to cancer or infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for cancer and infectious diseases.
How similar studies have performed: Previous research has shown promise in developing new synthesis methods for bioactive compounds, indicating potential success for this innovative approach.
Where this research is happening
RICHARDSON, UNITED STATES
- UNIVERSITY OF TEXAS DALLAS — RICHARDSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROMITI, FILIPPO — UNIVERSITY OF TEXAS DALLAS
- Study coordinator: ROMITI, FILIPPO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: anti-cancer therapy, cancer therapy, Cancer Treatment, cancer-directed therapy, Communicable Diseases